Furukawa C T
J Allergy Clin Immunol. 1984 May;73(5 Pt 2):693-8. doi: 10.1016/0091-6749(84)90308-7.
Although most asthmatic athletes can be adequately controlled by beta-adrenergic agents, sodium cromolyn, and/or theophylline, a few do not tolerate these medications or have suboptimal results. Cromolyn-like antiallergic drugs, newer antihistamine, antiserotonin, and antileukotriene agents as well as calcium channel blockers, antimuscarinics , alpha-adrenergic blockers, and new steroid preparations may be suitable for these individuals. Although efficacy has been demonstrated for a number of these new agents, much work remains to be done to evaluate thoroughly their potential pharmacologic effectiveness in exercise-induced asthma.
虽然大多数哮喘运动员可以通过β-肾上腺素能药物、色甘酸钠和/或茶碱得到充分控制，但少数人不能耐受这些药物或效果欠佳。类色甘酸抗过敏药物、新型抗组胺药、抗血清素和抗白三烯药物，以及钙通道阻滞剂、抗毒蕈碱药物、α-肾上腺素能阻滞剂和新型类固醇制剂可能适用于这些人。虽然已证明许多这些新药具有疗效，但要全面评估它们在运动诱发哮喘中的潜在药理效果，仍有许多工作要做。
